Clinical Trials Directory

Trials / Completed

CompletedNCT06152094

UCSF BP Activate Letter Study

UCSF BP Activate Letter Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
484 (actual)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The BP Activate Study aims to assess the effectiveness of the BP Report letter with personalized BP medication recommendations, compared with Control letters and no intervention, at shortening time to appointment, time to visit, time to medication change, and time to achievement of BP goal.

Detailed description

The BP Activate Study is a randomized quality improvement trial. We will deliver one of two versions of a letter to established English-speaking primary care patients at Mt Zion with uncontrolled hypertension, defined by SBP\>140 or DBP\>90 in the past two years (identified via EHR). The letter will prompt patients to schedule a visit with their provider or team nurse practitioner to discuss their BP recommendations with their clinician. We will test 2 versions of the letter and a usual care control: 1. The "BP Activate Report Letter" group will get a letter that presents recommendations for medication changes from a computerized algorithm using the patient's medical records and recommends discussing these specific recommendations with their clinician; or 2. The "Control Letter" group will get a letter that suggests they talk to their clinician about their BP without providing any specific medication recommendations. 3. The "Usual Care" group will not receive any intervention. This primary goal of the study is to assess the effectiveness of the BP Activate Report Letter compared with the Control Letter, and see if it shortens time to appointment, time to visit, time to medication change (primary outcome), and time to achievement of BP goal. Clinicians, with patient input, will still have full control of how BP is clinically managed. A small number of patients will be contacted by a research coordinator to hear what they thought when they received the letter, and why they did or did not act upon the information.

Conditions

Interventions

TypeNameDescription
OTHERBP Activate LetterParticipants in the BP Activate Letter arm will receive a BP Activate Report that includes personalized details about recent measurements, current medications, and "computer-generated medication recommendations that might improve your blood pressure", along with a log for tracking additional SMBP measurements. They will also receive a cover letter that includes an assessment that BP appears to be uncontrolled, and suggesting a visit with their provider to discuss.
OTHERControl LetterParticipants in the Control Letter arm will receive a cover letter that includes an assessment that BP appears to be uncontrolled, and suggesting a visit with their provider to discuss.

Timeline

Start date
2023-07-20
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2023-11-30
Last updated
2025-01-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06152094. Inclusion in this directory is not an endorsement.